India-first daily coverage of GLP-1 therapy — DCGI approvals, Indian generic launches (Sundae, Noveltreat, Obeda, Semabest…), price cuts, Mounjaro / tirzepatide updates, and trial readouts (STEP, SUSTAIN, SURMOUNT, SELECT).
Weight-loss drug semaglutide set to get cheaper as generic wave builds in India The Economic Times
Cheaper generic Ozempic is coming soon — but not for Americans. Here’s why. NBC News
Generic semaglutide in India: Game changer or gamble? The South First
Will Novo Launch Wegovy Pill In India As Generics Match Its Semaglutide Sales? Citeline News & Insights
On a GLP-1? These Cookbooks Can Make or Break Your Nutrition Everyday Health
Once-daily orforglipron helps preserve weight loss after semaglutide or tirzepatide News-Medical
Patients Over 65 With Obesity Respond Well to Semaglutide Medscape
First Clinical Trial for a GLP-1 Gene Therapy Greenlit in Europe Inside Precision Medicine
FDA Proposes to Exclude GLP-1s From 503B Bulk List Drug Topics
FTC Blocked From Endocrine Society Probe; FDA-Tzield Drama; GLP-1 Gene Therapy? MedPage Today
Hims & Hers Shifts Strategy to Offer Comprehensive FDA-Approved GLP-1 Access The Healthcare Technology Report.
Gala Health GLP-1 Compounded and Branded Weight Loss Medication Options with Real Doctor Support The Manila Times
Canada approves generic semaglutide from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent drugdiscoverytrends.com
Novo Nordisk data shows oral semaglutide delivers significant weight loss in phase 3 trial PharmaTimes
Eli Lilly shows sustained weight loss in new pill study medwatch.com
Eli Lilly Extends Tirzepatide Push With New Phase 4 Study in India TipRanks
News articles are aggregated from third-party RSS feeds. GLP-1 Check does not endorse or verify individual articles. Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.
